» Articles » PMID: 19747951

Regulation and Function of the Cytosolic Viral RNA Sensor RIG-I in Pancreatic Beta Cells

Overview
Specialties Biochemistry
Biophysics
Date 2009 Sep 15
PMID 19747951
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Enteroviral infections are associated with type I diabetes. The mechanisms by which viruses or viral products such as double-stranded RNA (dsRNA) affect pancreatic beta cell function and survival remain unclear. We have shown that extracellular dsRNA induces beta cell death via Toll-like receptor-3 (TLR3) signaling whereas cytosolic dsRNA triggers the production of type I interferons and apoptosis via a TLR3-independent process. We presently examined expression of the intracellular viral RNA sensors, the RNA helicases RIG-I and MDA5, and documented the functionality of RIG-I in pancreatic beta cells. FACS-purified rat beta cells and islet cells from wild-type or TLR3(-/-) mice were cultured with or without the RIG-I-specific ligand 5'-triphosphate single-stranded RNA (5'triP-ssRNA), the synthetic dsRNA polyI:C (PIC) or 5'OH-ssRNA (negative control); the RNA compounds were added in the medium or transfected in the cells using lipofectamine. RIG-I and MDA5 expression were determined by real-time RT-PCR. NF-kappaB and IFN-beta promoter activation were studied in the presence or absence of a dominant-negative form of RIG-I (DN-RIG-I). Both extracellular (PICex) and intracellular (PICin) PIC increased expression of RIG-I and MDA5 in pancreatic beta cells. TLR3 deletion abolished PICex-induced up-regulation of the helicases in beta cells but not in dendritic cells. PICin-induced NF-kappaB and IFN-beta promoter activation were prevented by the DN-RIG-I. The RIG-I-specific ligand 5'triP-ssRNA induced IFN-beta promoter activation and beta cell apoptosis. Our results suggest that the RIG-I pathway is present and active in beta cells and could contribute to the induction of insulitis by viral RNA intermediates.

Citing Articles

Circular RNA vaccine in disease prevention and treatment.

Niu D, Wu Y, Lian J Signal Transduct Target Ther. 2023; 8(1):341.

PMID: 37691066 PMC: 10493228. DOI: 10.1038/s41392-023-01561-x.


Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?.

Eizirik D, Szymczak F, Mallone R Nat Rev Endocrinol. 2023; 19(7):425-434.

PMID: 37072614 DOI: 10.1038/s41574-023-00826-3.


dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects.

Chattopadhyay S, Sen G J Interferon Cytokine Res. 2014; 34(6):427-36.

PMID: 24905199 PMC: 4046345. DOI: 10.1089/jir.2014.0034.


The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?.

Soleimanpour S, Stoffers D Trends Endocrinol Metab. 2013; 24(7):324-31.

PMID: 23647931 PMC: 3908840. DOI: 10.1016/j.tem.2013.03.005.


Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice.

McCall K, Schmerr M, Thuma J, James C, Courreges M, Benencia F Molecules. 2013; 18(4):3841-58.

PMID: 23535518 PMC: 6269916. DOI: 10.3390/molecules18043841.